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INTRODUCTION
Horses (Equus caballus) are valued by breeders and enthusiasts for their beauty and variety of coat color and white spotting patterns. The genetic bases for several different white spotting patterning in horses have been reported, including those for Frame Overo, Sabino-1, Tobiano, Dominant White spotting and Gray [1] [2] [3] [4] [5] . The gene for Leopard Complex spotting (also referred to as Appaloosa spotting) has been mapped to horse chromosome 1 (ECA1) but the molecular basis has not been identified [6] .
Leopard Complex spotting is found in several breeds of horses including Appaloosa, Knabstrupper, Noriker, Pony of the Americas, American Miniature and British Spotted Pony, among others. This spotting is characterized by several different patterns and associated traits. All of these patterns are characterized by patches of white in the coat that tend to be symmetrical and centred over the hips [7] . The patterns differ by the extent of white on the individual ( Figure 1 ) and range from horses that display only a few white flecks on their rump to horses that are nearly all white, known as the 'fewspot' pattern.
Leopard Complex spotting was named after one of the spotting patterns 'leopard' ( Figure 1D ) in which characteristic pigmented oval spots (termed 'leopard spots') are observed in the white patterned area [7, 8] . In addition to the white patterning and leopard spots, Leopard Complex spotting is associated with four additional pigmentation traits (known as 'characteristics') that include striped hooves, readily visible unpigmented sclera around the eye, mottled pigmentation around the anus, genitalia and muzzle, and LP-specific roaning ( Figure 2 ) [8] .
A single incompletely dominant autosomal locus, LP, controls for the presence or absence of these pigmentation patterns and their associated characteristics. This was established by following the breeding records of hundreds of horses in the Appaloosa breed as well as other breeds that segregate for LP [7, 9] . Modifiers are thought to be responsible for the multiplicity of patterns associated with Leopard Complex spotting [7] [8] [9] . Horses that inherit the dominant allele LP LP will have the associated characteristics as well as display one of several different patterns of white ( Figure 1 ). Homozygotes LP LP 
/LP
LP tend to have few to no leopard spots, whereas heterozygotes typically have leopard spots in their white patterned area [7, 10] . Similar phenotypes are known to occur in other species but none have been reported to display the myriad of patterning associated with LP [11] [12] [13] .
Often white spotting in mammals is associated with other pleiotropic effects. In humans hypopigmentation of the skin is often associated with developmental defects of the eye. These disorders are commonly known as albinism [14] . In horses the only reported link between white spotting and eye disorders occurs with the Leopard Complex spotting. We have recently reported an association between homozygosity for LP in the Appaloosa and congenital stationary night blindness (CSNB) [15, 16] .
LP was linkage mapped to a 6 cM region on ECA1 between microsatellite markers ASB8 and 1CA043 [6] . Included in this interval is the positional and functional candidate gene encoding the Transient Receptor Potential Cation Channel, Subfamily M, Member 1 (TRPM1) [17] . TRPM1 is a member of the transient receptor potential (TRP) channel family, a family of proteins thought to be important in cellular and somatosensory perception [18] . Recently, qRT-PCR analyses showed that TRPM1 mRNA expression is significantly down-regulated in both the skin of homozygotes (LP LP /LP LP ) and the retina of CSNB-affected Appaloosas, whereas four other linked genes had unaltered mRNA expression [16] . This evidence suggests that the differential expression of TRPM1 may Horse displaying the 'Lace Blanket' pattern, a small amount of white spotting is detected on the rump of the animal. (C) The 'Spotted Blanket' pattern, white is centred over the rump and can extend from the croup to the withers. Pigmented spots are present in the white patterned area. (D) The 'Leopard' pattern, white extends almost over the entire body and pigment spots are present in the white areas. (E) The 'Snowcap Blanket' pattern, white can extend from the croup to the withers but with few to no pigmented spots in the white patterned area. (F) The 'Few Spot' pattern, white extends almost over the entire body with few to no pigmented spots. All of these patterns are caused by a single dominant allele at the LP locus. E and F represent the homozygous genotypes, C and D are typical of heterozygotes and often the genotypes of horses similar to (A and B) cannot be determined from phenotype alone.
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interfere with signaling for survival, differentiation and/or function of the melanocyte, in addition to the ON bipolar cell in the retinal rod pathway. The causative mutation for LPand CSNB remains unknown although it is highly associated with the expression or stability of TRPM1 mRNA. In this study, we describe the mutation detection over the LP and CSNB locus. Within the previously linked interval we focused our efforts in the vicinity of TRPM1. First, the proximal promoter and coding regions (based on comparisons to human and mouse sequences) were sequenced. When no mutations explaining the expressional difference were detected, we refined the linked interval by fine mapping and identified potentially functional mutations by targeted sequencing.
MATERIALS AND METHODS Horses
Horses from three different breeds known to segregate for LP were used in this study namely Figure  1E and F) [7, 10] . Horses in the LP LP /LP lp group all displayed white patterning with leopard spots ('leopard' or 'spotted blanket') and/or had breeding records consistent with heterozygosity (only one LP carrying parent) ( Figure 1C 
Ophthalmic examinations
Thirty of these horses used in both the SNP association and fine mapping studies were categorized by ocular examination as previously described [16] . Twenty-five of these horses were Appaloosas, two were Knabstruppers and three were American Quarter Horse controls. An a-wave-dominated ERG or 'negative ERG' was considered diagnostic of CSNB [15] 
DNA extraction
In addition to the previously archived Thoroughbred samples, whole blood or mane hair was collected by one of the authors or submitted by owners for this study. DNA from blood samples was extracted either using the Puregene whole-blood extraction kit (Qiagen Inc., Valencia, CA, USA) or Nucleon Bacc2 kit (GE Healthcare Bio-Sciences Corp., Piscataway, NJ, USA) according to the manufacturer's protocol. Hair samples were processed using 5-7 hair bulbs according to the method described [19] . Briefly, the hair bulbs were placed in a 100 ml lysis solution of FastStart Taq Polymerase PCR buffer (Roche, Mannheim, Germany), 2.5 mM MgCl 2 (Roche), 0.5% Tween 20 (JT Baker, Phillipsburg, NJ, USA) and 0.01 mg proteinase K (SigmaAldrich, St Louis, MO, USA) and incubated at 60 C for 45 min, followed by 95 C for 45 min to deactivate the proteinase K.
DNA sequencing: putative regulatory regions and exons
Primers to amplify and sequence putative regulatory regions, exons and flanking introns of TRPM1 were designed based on the publically available equine genome sequence. Specifically, the equine proximal promoter sequence was identified from the equine Trace Archive by performing BLAST searches using the human and mouse TRPM1 proximal promoter sequences [20] [21] [22] . Homo sapiens miRNA within the TRPM1 gene (Accession: MI0000287 ID: hsa-mir-211) was used to identify homologous miRNA sequence in horse [22] [23] [24] . Homo sapiens TRPM1 transcript (Refseq: NM 002420, Ensembl transcript ID ENST00000256552) was used to identify equine homologous exons and flanking intron sequences by BLAST or BLAT searches [22, 25] . Exons 3-27 were confirmed by cDNA sequencing from retinal RNA. Primers were designed for the homologous horse sequences using Primer 3 software [26] .
DNA from one solid non-Appaloosa (LP 
SNP association
A SNP detected from the LP LP /LP LP sample in introns 11-12 (ECA1:108,249,293 C>T) showed complete association in the panel of 10 horses tested. The association of this SNP with LP and CSNB was further tested by either direct sequencing or by a BsmFI PCR-RFLP. Specifically PCR template for digestion was amplified in 10 ml PCR reactions using 1Â PCR buffer with 2.0 mM MgCl 2 , 100 mM of each dNTP, 1 ml genomic DNA from hair lysate, 0.1 U FastStartTaq DNA polymerase (Perkin Elmer) and 200 nM of each primer (forward: 5 0 -GACTGAGCGTATGTGCGTGT-3 0 and reverse: 5 0 -CTCCTGTCTGAGTGGCTTC A-3 0 ). PCR reactions were performed at an annealing temperature of 64 C for 35 cycles. PCR products were digested for 14 h at 65 C according to the manufacturer's protocol using 2 U BsmFI (New England BioLabs Inc., Ipswich, MA, USA). Digested PCR products were analyzed on a 1.5% agarose gel stained with EtBr and illuminated by ultraviolet light. This RFLP was designed with an internal cut site that generated a 529 bp and 100 bp product. This enzyme also recognized the ECA1:108,249,293:C allele generating a product that was 362 bp and one that was 167 bp. A total of 357 horses from three different breeds known to have Leopard Complex spotting were tested. As a control group, 32 Thoroughbreds, not expected to have the LP mutation, were also tested. SNP genotypes were analyzed for the association with LP genotype by chi-squared analysis.
Fine mapping
Seventy SNPs spanning over 2 Mb (ECA1:107, 194,138-109,299,508) and encompassing the candidate gene TRPM1 were used to fine map LP and CSNB. These SNPs, previously identified in the 2007 (EquCab2) assembly (http://www.ensembl.org/Equus_caballus/index.html) of the horse genome, were genotyped in all 192 horses by the Sequenom Mass Spectrometry platform using the iPlex system [27] . The MassARRAY Designer software was used to design both PCR and MassEXTEND primers for all mutiplexed assays. The 70 SNPs were multiplexed in 35 plexes. All SNPs tested, PCR primer sequences and extension temperatures are listed in Supplementary Table S2 . SNP genotypes were analysed for association with the LP genotype by the chi-squared analysis by breed. Then to maximize haplotype association, final analysis was performed with homozygous samples only (LP
lp ) in all breeds tested using Haploview [28] .
Mutation screening of fine-mapped region
A 300 kb region of highest association was resequenced in two homozygous horses (LP [29, 30] . In order to identify polymorphisms of interest, the short sequence reads (35 bp) were assembled and aligned with the horse reference genome sequence using MAQ alignment software [31] . This program uses a quality scoring matrix to assemble short reads to derive SNP calls based on a consensus diploid reference genome. Under a more stringent analysis, Spines was used to align all of the sequenced reads and a minimum coverage of 5-fold was required to call a polymorphic base (http://www.broadinstitute .org/science/programs/genome-biology/spines). 
/LP
lp Thoroughbred) was further evaluated to determine if the mutation was located within conserved or transcribed regions. Conserved intervals were identified using Siphy [32] and comparing the SNP regions across 29 different eutherian mammalian species. Siphy allows for the comparisons of many related sequenced genomes to identify functional elements in a reference genome. The potential of SNPs to be transcribed was determined by comparing the location of individual SNPs with RNA sequence coverage data [33] .
RESULTS

TRPM1 targeted sequencing
Initial DNA sequencing was performed on coding sequence, flanking intron sequence (FIS) and putative regulatory regions of TRPM1 including the proximal promoter, a putative internal miRNA gene, 5 0 -and 3 0 -UTRs and $0. This exon is present in humans but was not detected in either horse retina or skin transcripts. SNPs identified only in the LP/LP sample sequenced are in larger font and in bold print.
Fine-mapping and mutation analysis of TRPM1 2 ¼ 120, P << 0.0005). However, this association was not complete, in that 34 horses not suspected to have an LP allele possessed at least one copy of the T allele and two horses suspected to be heterozygous for LP were homozygous for this SNP (Table 2 ).
Interval refinement by fine mapping
A set of 70 SNPs, identified as part of the whole-genome sequencing in the horse [34] Figure 3A ). The most associated SNP occurred at position ECA1: 108,370,091 ( 2 ¼ 117, P ¼ 2.3 Â 10 À27 ) in a region upstream of the suspected protein-coding region for TRPM1 ( Figure 3B ). The second most associated SNP occurred in an intron of TRPM1 (intron 11) ECA1:108,248,113 ( 2 ¼ 97, P ¼ 6.2 Â 10 À23 ) (Table 3, Figure 3 ). Both of these SNPs are within the observed associated haplotype.
Comparing only CSNB-phenotyped horses (cases/controls ¼ 14/16), three SNPs were found to be significantly associated (P < 1 Â 10 À06 ). The strongest association occurred close together at positions ECA1:108,370,091 and ECA1: 108,370, 150 ( 2 ¼ 28, P ¼ 1.6 Â 10 À07 ) ( Table 4 , Figure 3 ). The only annotated gene in this region is TRPM1 ( Figure 3B ).
Targeted re-sequencing
A region (EquCab2.0 chr1:108,199,741-108, 500,045), encompassing the LP haplotype detected Thoroughbred is a breed of horses not expected to have the LP allele and thus served as a control. This SNP showed perfect association with CSNB and LP in Appaloosas and Knabstruppers but was less associated with phenotype in the Noriker breed. LP genotype was predicted by breeding and photographic records; CSNB phenotype was determined by ERG as described in the article. N represents the number of horses tested in each breed.
by fine mapping, was investigated by NimbleGen hybrid capture for target sequence enrichment followed by Illumina Genome Analyzer sequencing. Initially, the sequence for analysis required base coverage >5-fold for each horse sequenced. In all, 359 differences, compared to the reference genome sequence, were identified in the sequenced region among all six horses sequenced ( 
DISCUSSION
Previous linkage and gene expression data implicated a TRPM1 mutation as the cause for both LP and CSNB. DNA sequencing of the putative coding and regulatory regions identified one non-coding SNP (ECA1:108,249,293 C>T) that was highly associated with both CSNB and LP. However, this SNP did not show complete concordance with the LP genotype in the Noriker breed and we concluded that this SNP was not causative for LP. Nevertheless, because this SNP exhibits strong linkage disequilibrium with LP, it could be used as a genetic marker to test for zygosity for LP and CSNB for the Appaloosa and Knabstrupper horses, as many horses are born with low amounts of white patterning that do not allow a precise assignment of their genotype by their phenotype ( Figure 1A and B) .
Given the large difference in mRNA prevalence previously observed, it was hypothesized that a mutation in the proximal promoter causes this expression difference. Our results do not support this hypothesis; no mutation was detected in this region. However, sequence analysis provided verification that the equine proximal promoter is similar to both the described promoters for mouse and human having four potential MITF binding sites, a CAT box and a non-consensus TATA box (Figure 4) [20, 21] .
Translation of the human full-length TRPM1 protein of 1533 amino acids was previously reported to begin in exon 3 and end in exon 27 [35] . Equine gene predictions were not available when the TRPM1 coding region sequencing was underway; therefore, the equine exonic structure (exons as predicted by extrapolating from the human assembly (Refseq: NM 002420, Ensembl transcript ID ENST00000256552) was verified by cDNA sequencing from RNA isolated from the retina (Table 1) . Exon 23 as denoted in human nomenclature (currently listed as the predicted exon 24 for horse by Ensembl transcript ID ENSECAT00000009109) was not detected in cDNA sequencing of either retina or skin. Therefore, sequencing the exons enabled the identification of deviations from human sequence and from the predicted gene structure. Further work is needed to characterize the upstream exons that have been recently identified in other species as described in refs [36, 37] and below.
Although a mutation in the proximal promoter or protein coding sequence that could explain the expressional difference detected was not identified, fine mapping reduced the candidate region from $10 Mb to a considerably smaller region of 300 kb that included a single 173 kb associated haplotype (ECA1: 108,197,355-108,370,150). The region includes part of the coding sequence of TRPM1 as well as a region upstream of the coding region for this gene. According to UCSC and Ensembl genome browsers, no functional genes have been annotated in this upstream region in the horse [38, 39] . Therefore, this region may contain important regulatory elements for TRPM1 and thus should be further investigated for potential consensus regulatory elements. Furthermore, recently an additional 5 0 -exon was identified in the retina of mouse and rat (described as 1a) and melanocytes, retina and brain in humans (described as exon 0) [36, 37] . Surprisingly, this exon is located over 30 kb and 58 kb upstream of the described proximal promoter in mouse and human, respectively. This exon contains an in-frame translation start site and thus results in an alternative longer isoform of TRPM1. It is likely that an additional promoter exists that drives the expression of this alternative upstream exon and this should be investigated as the cause for CSNB and LP in horses. Human and mouse amino Fine-mapping and mutation analysis of TRPM1acid sequences were used to BLAT [25, 38] the horse genome and the homologous sequence for this exon was obtained (ECA1: 108,336,195-108,336,121). The expression of this exon in the horse should be verified by RNA seq or RT-PCR in retina and melanocytes. Our re-sequencing efforts did not identify any candidate mutations in this region. The closest candidate SNP (ECA1: 108,337,089) was 894 bp away and while this SNP is not in a region that has previously been shown to be transcribed or conserved, this SNP could be within a yet undescribed distal promoter and should be further investigated.
Re-sequencing over the 300 kb region of highest association using high stringency parameters (coverage of 5Â or greater) identified three other polymorphisms in either highly conserved (1) or potentially transcribed regions (2) . While using lower stringency (coverage of 1Â) identified two additional polymorphisms (one transcribed and one conserved), which should also be investigated for the association with LP and CSNB in all breeds segregating for these phenotypes. Specifically, SNP ECA1:108, 489,901 G>A and ECA1:108,497,669 C>A are located in the regions conserved across 29 [33] . This emphasizes the importance and necessity of species-specific gene annotation confirmation. In humans, at least five isoforms of TRPM1 exist [37] , in addition to the longer isoform produced by exon 0 described above, another isoform known as 92 þ TRPM1 results from an alternative exon with a start codon (exon 1 0 ) located between exons 1 and 2. The horse RNA sequencing data [33] provide evidence that this exon may exist in the horse and therefore these SNPs should be investigated further for association and expression within TRPM1 isoforms in the skin and retina of the horse.
While the causative mutation for CSNB and LP remains unknown, we have identified a SNP (ECA1:108,249,293 C>T) within TRPM1 that can be used for genotyping for CSNB and LP in Appaloosas until the causative mutation has been identified. We have also provided additional evidence that TRPM1 is the genetic cause of both CSNB and LP and have identified six additional polymorphisms to examine for the association with LP and CSNB. This investigation is underway. Through our analysis we have discovered the need for further annotation and characterization of the equine TRPM1 gene, specifically with respect to regulatory regions, characterization of alternative 5 0 -exons, as well as determining functional isoforms. The precise function of TRPM1 remains to be fully elucidated. This protein belongs to the Ca 2þ transient receptor potential superfamily. Ca 2þ signaling and sensation have obvious roles in both cell migration and signaling. Thus through our studies on LP and CSNB it has become apparent that TRPM1 likely plays a role in both melanocyte and ON bipolar cell functioning. Several recent functional and comparative mapping studies in other species substantiate this argument. Work by Shen et al. suggested that TRPM1 is essential for synaptic function of the metabotropic glutamate receptor (MGluR6) pathway in ON bipolar cells as evidenced by the negative ERG (similar to the ERG observed in CSNB Appaloosas) in Trpm1 knockout mice [40] . A similar form of CSNB has been diagnosed in humans, known as the Schubert-Bornshein type [41, 42] ; however, to date, no pigmentation disorders have been reported with this form of CSNB in humans [43] . Mutations in an X-linked gene, NYX, have been shown to cause some of the CSNB cases in humans [44] . Very recently, in humans, several causative mutations for CSNB have been identified in TRPM1 [43, [45] [46] . However, none of these have been correlated with gene expression and none are located in the regions of our candidate SNPs. Furthermore, several cases in humans were not explained by detected mutations [45] ; thus, identifying the mutation that causes CSNB in Appaloosa horses may help to identify the genetic cause in yet unresolved SchubertBornshein types of human CSNB and may also help identify the molecular link between NYX, TRPM1, and other genes.
In mice, the appearance of white in the coat results from the absence of mature melanocytes caused by defects at various stages of melanocyte development. Many genes have been described that affect this development [47] , but none have been shown to cause the many variations of spotting as seen with LP. FurthermoreTRPM1 has not been described as a coat color gene. Recent work, however, by Oancea et al. has demonstrated that TRPM1 expression correlates with the melanin concentration suggesting a potential role for TRPM1 in the storage of melanin [37] . The functional question for LP spotting remains: is the white spotting caused by the lack of melanocytes, disruption in the function of melanocytes, or both. Transcriptional regulation and processing resulting in different isoforms for this and other TRP genes are thought to be responsible for functional variability [36] . Thus it is possible that different isoforms of TRPM1 may be involved in melanocyte migration while others are involved in melanin storage or transfer from melanocyte to keratinocyte or hair follicular cells. TRPM1 could be important for calcium concentration gradients leading to melanocyte migration during development (as TRPM7 assists migrating fibroblasts) [48] . Failure of the calcium gradient oscillation might cause the absence of pigmentation seen in LP spotting patterns and associated characteristics. Furthermore, melanin storage deficiencies may explain why horses with LP roan with age. Identifying the genetic mutation affecting TRPM1 that causes LP and CSNB in the horse will both enrich our understanding of TRPM1 function and will help to explain yet unresolved forms of human CSNB and pigmentation disorders.
SUPPLEMENTARY DATA
Supplementary data are available online http:\\bfgp .oxfordjournals.org.
Key Points
Utilization of the equine genome for regional SNP mapping and Illumina sequencing successfully identified six candidate SNPs for further investigation and provided strong evidence that TRPM1 is the locus responsible for both CSNB and LP. LP spotting serves as an important model to gain further insight into melanocyte biology, retinal bipolar cell signaling and the genetic connection between these processes. Our Illumina data illustrate the importance of coverage consideration with these types of sequencing data; high coverage helps to eliminate not only erroneous base calls but also potential causative SNPs. SNPs from low coverage reads should be considered and investigated appropriately. Similar white spotting phenotypes occur in other species; however, no other species display the multiplicity of patterns controlled by a single locus. In addition, none of these phenotypes have been attributed to variants in theTRPM1 gene. In humans, several different mutations have been shown to cause CSNB, none of which has been associated with a pigmentation disorder. TRPM1 is expressed in multiple isoforms and these specific isoforms, as they relate to function, need to be characterized in the horse.
